Reaction

Rheumatoid Lung reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 951 reports · 48 co-occurring drugs

As of the last recalculation, Rheumatoid Lung appears in 951 FAERS reports alongside 48 co-occurring drug terms. The strongest observed disproportionality signal is METHYLPREDNISOLONE ACETATE (PRR 175.0).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Methylprednisolone Acetate	60	175.0	176.3
Dimenhydrinate	49	106.1	106.5
Febuxostat Tablets 40 Mg	45	101.6	102.1
Febuxostat Tablets 80 Mg	45	101.6	102.1
Leflunomide	306	93.9	94.2
Hydroxychloroquine Sulfate	207	63.3	63.4
Febuxostat	46	63.1	63.2
Hydroxychloroquine	161	56.6	56.7
Abatacept	241	50.7	50.8
Tocilizumab	196	47.1	47.2
Adalimumab-Fkjp	90	46.9	47.0
Adalimumab-Aaty	90	45.9	46.0
Adalimumab-Adaz	93	42.6	42.7
Risedronate Sodium	56	41.8	41.9
Colchicine	46	40.1	40.2
Diphenhydramine Hydrochloride Capsule, Liquid Filled	37	39.4	39.5
Naproxen Sodium Tablet, Coated	23	38.1	38.1
Naproxen Sodium, Coated Tablets	23	38.1	38.1
Naproxen Sodium 220Mg	23	38.0	38.1
Methotrexate Sodium	451	37.7	37.8
Methotrexate	407	36.3	36.3
Sulfasalazine	113	35.7	35.8
Diclofenac	112	32.1	32.2
Ibuprofen And Diphenhydramine Citrate	33	32.1	32.2
Tofacitinib	199	29.6	29.6
Naproxen	95	29.3	29.3
Meloxicam	66	26.6	26.7
Dexlansoprazole	48	26.5	26.5
Golimumab	87	24.3	24.4
Moxifloxacin Hydrochloride	19	20.9	20.9
Baricitinib	9	20.6	20.6
Celecoxib	108	20.1	20.1
Diclofenac Sodium	115	18.9	18.9
Adalimumab	366	17.8	17.8
Diclofenac Sodium 1%	28	17.6	17.7
Diclofenac Sodium Topical	28	17.6	17.7
Diclofenac Sodium Topical Gel, 1%	28	17.6	17.6
Naproxen Sodium	102	17.4	17.4
Certolizumab Pegol	83	16.9	16.9
Alendronate Sodium Tablet	14	16.8	16.8
Cyclosporine	78	16.6	16.6
Desoximetasone	14	16.3	16.3
Infliximab	136	15.7	15.7
Liothyronine Sodium	6	15.2	15.2
Etanercept	291	14.9	14.9
Ustekinumab	44	9.8	9.8
Secukinumab	55	7.9	7.9
Apremilast	47	7.3	7.3

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.